![]() | |
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C23H31N3OSi |
Molar mass | 393.606 g·mol−1 |
3D model (JSmol) | |
| |
|
CUMYL-3TMS-PRINACA is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first identified in Sweden in May 2023. Along with the related compound ADMB-3TMS-PRINACA that was reported several months earlier, CUMYL-3TMS-PRINACA is one of the only psychoactive drugs ever reported that contains a silicon atom. [1] Another example of a silicon-containing drug is sila-haloperidol. [2]
CUMYL-3TMS-PRINACA is illegal in Germany and Italy and has been recommended for control in Sweden. [3] [4]
Update of the tables containing the indication of narcotic and psychotropic substances, pursuant to the decree of the President of the Republic of 9 October 1990, n. 309 and subsequent amendments and additions. Inclusion in Table I of the specific indication of the substances: MDMB-BINACA; N-sec-butyl-pentedrone; CUMIL-3TMS-PRINACA. (23A06995) (GU General Series n.300 of 27-12-2023)